Stockreport

PrimeC New Data to Be Presented at AD/PD™ 2026 Conference

NeuroSense Therapeutics Ltd.  (NRSN) 
PDF Dr. Christian Lunetta to Present "From PARADIGM to PARAGON: Advancing PrimeC for ALS through Phase 2 Clinical and Biomarker Insights toward a Global Phase 3 Trial"CAMBRI [Read more]